Dr. Nathan Katz, co-founder, CEO, and Chief Scientist at Jointechlabs, is an industry leader in orthobiologic regenerative and rejuvenation therapies. Following his PhD in cell biology, Dr. Katz quickly became part of the growing field of stem cells and reproductive medicine.
Shortly afterward, foundational papers were presented on adipose-derived stem cells which intrigued Dr. Katz. He was specifically motivated to explore these disciplines, since his mother was suffering the debilitating effects of osteoarthritis.
After years of research and testing, Dr. Katz co-founded Jointechlabs to promote efficient ways of adipose regenerative cell harvest, which can then be used for several therapeutic applications.
The company was founded on the principle of making efficient, affordable adipose regenerative cell therapies available to doctors and patients around the world. This principle continues to guide the company today. Dr. Nathan Katz and Dr. Nishit Pancholi aim to advance the field of regenerative practice and make it an available standard-of-care option for doctors and patients. Their combined efforts have led to novel product developments, enabling healthcare professionals to offer affordable autologous adipose-based therapies for their patients at the point of care.